Subsequently, YAP1 was reported to be associated with tumor progression and patients’ prognosis in various kinds of cancers including bladder cancer, breast cancer, gastric cancer, head and neck cancers, colorectal cancer, and pancreatic ductal adenocarcinoma (PAAD) [4–9]. This evidence concerns the gene YAP1 and breast cancer.